Pneumonia, Ventilator-Associated
60
6
7
30
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.0%
9 terminated out of 60 trials
76.9%
-9.6% vs benchmark
20%
12 trials in Phase 3/4
33%
10 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (60)
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Biomarkers for Ventilator-associated Pneumonia
BIS in ICU Interventional Study
TRacheal Cuff PRessure Evaluation Study
The Efficacy of Adjuvant Oral Care in Prevention of Ventilator Associated Pneumonia.
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia
Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia
Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients
Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response
Lung Ultrasound-guided Fluid Therapy in Pediatric Intensive Care Unit Patients
PROUD Study: A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region
Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Preoperative Optimization to Improve Functional Status
Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia
FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units
Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
CTTI Risk Factors for HABP/VABP Study
Weekly Versus no Routine Ventilator Circuit Changes in NICU